Suppr超能文献

Mdm2基因发生突变且该突变干扰MDM2与核糖体蛋白结合的小鼠,其红细胞生成出现缺陷。

Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.

作者信息

Kamio Takuya, Gu Bai-wei, Olson Timothy S, Zhang Yanping, Mason Philip J, Bessler Monica

机构信息

Department of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.

Comprehensive Bone Marrow Failure Center, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.

出版信息

PLoS One. 2016 Apr 4;11(4):e0152263. doi: 10.1371/journal.pone.0152263. eCollection 2016.

Abstract

MDM2, an E3 ubiquitin ligase, is an important negative regulator of tumor suppressor p53. In turn the Mdm2 gene is a transcriptional target of p53, forming a negative feedback loop that is important in cell cycle control. It has recently become apparent that the ubiquitination of p53 by MDM2 can be inhibited when certain ribosomal proteins, including RPL5 and RPL11, bind to MDM2. This inhibition, and the resulting increase in p53 levels has been proposed to be responsible for the red cell aplasia seen in Diamond-Blackfan anemia (DBA) and in 5q- myelodysplastic syndrome (MDS). DBA and 5q- MDS are associated with inherited (DBA) or acquired (5q- MDS) haploinsufficiency of ribosomal proteins. A mutation in Mdm2 causing a C305F amino acid substitution blocks the binding of ribosomal proteins. Mice harboring this mutation (Mdm2C305F), retain a normal p53 response to DNA damage, but lack the p53 response to perturbations in ribosome biogenesis. While studying the interaction between RP haploinsufficiency and the Mdm2C305F mutation we noticed that Mdm2C305F homozygous mice had altered hematopoiesis. These mice developed a mild macrocytic anemia with reticulocytosis. In the bone marrow (BM), these mice showed a significant decrease in Ter119hi cells compared to wild type (WT) littermates, while no decrease in the number of mature erythroid cells (Ter119hiCD71low) was found in the spleen, which showed compensated bone marrow hematopoiesis. In methylcellulose cultures, BFU-E colonies from the mutant mice were slightly reduced in number and there was a significant reduction in CFU-E colony numbers in mutant mice compared with WT controls (p < 0.01). This erythropoietic defect was abrogated by concomitant p53 deficiency (Trp53ko/ko). Further investigation revealed that in Mdm2C305F animals, there was a decrease in Lin-Sca-1+c-Kit+ (LSK) cells, accompanied by significant decreases in multipotent progenitor (MPP) cells (p < 0.01). Competitive BM repopulation experiments showed that donor BM harboring the Mdm2C305F mutation possessed decreased repopulation capacity compared to WT BM, suggesting a functional stem cell deficit. These results suggest that there is a fine tuned balance in the interaction of ribosomal proteins with the MDM2/p53 axis which is important in normal hematopoiesis.

摘要

MDM2是一种E3泛素连接酶,是肿瘤抑制因子p53的重要负调控因子。反过来,Mdm2基因是p53的转录靶点,形成一个在细胞周期调控中起重要作用的负反馈环。最近有研究表明,当包括RPL5和RPL11在内的某些核糖体蛋白与MDM2结合时,MDM2对p53的泛素化作用会受到抑制。这种抑制作用以及由此导致的p53水平升高被认为是导致钻石-黑范贫血(DBA)和5q-骨髓增生异常综合征(MDS)中出现红细胞再生障碍的原因。DBA和5q- MDS与核糖体蛋白的遗传性(DBA)或后天性(5q- MDS)单倍体不足有关。Mdm2基因中的一个导致C305F氨基酸替换的突变会阻断核糖体蛋白的结合。携带这种突变的小鼠(Mdm2C305F)对DNA损伤仍保留正常的p53反应,但对核糖体生物合成的干扰缺乏p53反应。在研究核糖体蛋白单倍体不足与Mdm2C305F突变之间的相互作用时,我们注意到Mdm2C305F纯合小鼠的造血功能发生了改变。这些小鼠出现了轻度的大细胞性贫血并伴有网织红细胞增多。在骨髓(BM)中,与野生型(WT)同窝小鼠相比,这些小鼠的Ter119hi细胞数量显著减少,而在脾脏中未发现成熟红细胞(Ter119hiCD71low)数量减少,这表明脾脏出现了代偿性骨髓造血。在甲基纤维素培养基中培养时,突变小鼠的BFU-E集落数量略有减少,与WT对照组相比,突变小鼠的CFU-E集落数量显著减少(p < 0.01)。这种红细胞生成缺陷可通过同时缺乏p53(Trp53ko/ko)得到缓解。进一步研究发现,在Mdm2C305F动物中,Lin-Sca-1+c-Kit+(LSK)细胞数量减少,多能祖细胞(MPP)数量也显著减少(p < 0.01)。竞争性骨髓移植实验表明,携带Mdm2C305F突变的供体骨髓与WT骨髓相比,其移植能力下降,提示存在功能性干细胞缺陷。这些结果表明,核糖体蛋白与MDM2/p53轴之间的相互作用存在精细的平衡,这在正常造血过程中很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92bf/4820113/3dfad38c4859/pone.0152263.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验